東華大學圖書館 |

Investigating human diseases with the microbiome = metagenomics bench to bedside /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Investigating human diseases with the microbiome/ Huijue Jia.
其他題名:	metagenomics bench to bedside /
作者:	Jia, Huijue.
出版者:	Amsterdam :Academic Press, : 2022.,
面頁冊數:	1 online resource (ix, 216 p.)
內容註:	Intro -- Investigating Human Diseases with the Microbiome: Metagenomics Bench to Bedside -- Copyright -- Contents -- Acknowledgment -- Chapter 1 The supraorganism -- 1.1 New discoveries with new technology- A historical account -- 1.2 How many microbial cells can a human body have? -- 1.3 Viral particles in the human body -- 1.4 Microbiome in other species -- 1.5 Microbiome from ancient times -- 1.6 Summary -- References -- Chapter 2 Microbiota -- 2.1 Trophic levels in macroecology -- 2.2 Microbiome stability, diversity, and richness -- 2.3 De novo assembly of microbiota and robustness against invasions -- 2.4 Types of habitats for the skin microbiome -- 2.5 Forces shaping the oral microbiome -- 2.6 A stable gut microbiome -- 2.6.1 Adhesion -- 2.6.2 Peristalsis -- 2.7 "Enterotypes" and the Serengeti rules? -- 2.8 Summary -- References -- Chapter 3 Collecting samples for metagenomics -- 3.1 Nonmicrobial components in the sample that could influence DNA extraction and sequencing amount -- 3.2 Beware of contamination in each step, from stools to low-biomass samples -- 3.3 Reagents that prevent microbial growth after sampling -- 3.4 DNA extraction for metagenomic samples -- 3.5Sequencing amount -- 3.6 Taxonomic and functional profiles, absolute abundance -- 3.7 Sample size for metagenome-wide association studies -- 3.8 Summary -- References -- Chapter 4 Epidemiology in the human body -- 4.1 Analogy to COVID-19 --4.2 Sources of potential pathogens in the infant gut -- 4.3 Ectopic presence of commensal microbes -- 4.4 Get to where it matters for the disease -- 4.4.1 Rheumatoid arthritis -- 4.4.2 Cardiometabolic diseases -- 4.5 Interkingdom interactions in the microbiome in diseases -- 4.6 Other omics data that hint at a difference in microbiome -- 4.7 Summary -- References -- Chapter 5 The evolving microbial taxonomy.
內容註:	5.1 Approaching a closed reference set for routine applications -- 5.2 Sparser data with increasing taxonomic resolution -- 5.3 Evolutionary history below the species level -- 5.4 Whole-cell modeling to predict functional differences from genomic differences? -- 5.5 Summary -- References -- Chapter 6 Blurring the line between opportunistic pathogens and commensals -- 6.1 Causal reasoning 101 -- 6.2 Levels of existing evidence for the human microbiome and diseases -- 6.3 From microbes to molecules -- 6.3.1 Multiple effective molecules from Akkermansia muciniphila -- 6.3.2 Branched chain amino acids for muscles and diabetes -- 6.3.3 Molecular mimicry of autoantigens -- 6.3.4 Other examples, outer membranevesicles, phages -- 6.4 Summary -- References -- Chapter 7 Metagenomics from bench to bedside and from bedside to bench -- 7.1 Metagenomics for decision-making in diagnosis and treatment -- 7.1.1 Metagenomics for disease screening -- 7.1.2Metagenomics for personalized treatment -- 7.2 Further research to be inspired by clinical practice -- 7.3 Potential to modify existing categorization of diseases with knowledge of the microbiome -- 7.4 Summary -- References -- Chapter 8 Amicrobiome record for life -- 8.1 Proactive sampling of the microbiome at important time periods -- 8.1.1 A microbiome record from birth -- 8.1.2 Immediate and historical events for a wholesome microbiome -- 8.2 From genetic risk to the prevention of diseases -- 8.3 Summary -- References -- Index.
標題:	Medical microbiology. -
電子資源:	https://www.sciencedirect.com/science/book/9780323913690
ISBN:	9780323913706

Investigating human diseases with the microbiome = metagenomics bench to bedside /
Jia, Huijue.

Investigating human diseases with the microbiomemetagenomics bench to bedside /[electronic resource] :Huijue Jia. - Amsterdam :Academic Press,2022. - 1 online resource (ix, 216 p.)

Intro -- Investigating Human Diseases with the Microbiome: Metagenomics Bench to Bedside -- Copyright -- Contents -- Acknowledgment -- Chapter 1 The supraorganism -- 1.1 New discoveries with new technology- A historical account -- 1.2 How many microbial cells can a human body have? -- 1.3 Viral particles in the human body -- 1.4 Microbiome in other species -- 1.5 Microbiome from ancient times -- 1.6 Summary -- References -- Chapter 2 Microbiota -- 2.1 Trophic levels in macroecology -- 2.2 Microbiome stability, diversity, and richness -- 2.3 De novo assembly of microbiota and robustness against invasions -- 2.4 Types of habitats for the skin microbiome -- 2.5 Forces shaping the oral microbiome -- 2.6 A stable gut microbiome -- 2.6.1 Adhesion -- 2.6.2 Peristalsis -- 2.7 "Enterotypes" and the Serengeti rules? -- 2.8 Summary -- References -- Chapter 3 Collecting samples for metagenomics -- 3.1 Nonmicrobial components in the sample that could influence DNA extraction and sequencing amount -- 3.2 Beware of contamination in each step, from stools to low-biomass samples -- 3.3 Reagents that prevent microbial growth after sampling -- 3.4 DNA extraction for metagenomic samples -- 3.5Sequencing amount -- 3.6 Taxonomic and functional profiles, absolute abundance -- 3.7 Sample size for metagenome-wide association studies -- 3.8 Summary -- References -- Chapter 4 Epidemiology in the human body -- 4.1 Analogy to COVID-19 --4.2 Sources of potential pathogens in the infant gut -- 4.3 Ectopic presence of commensal microbes -- 4.4 Get to where it matters for the disease -- 4.4.1 Rheumatoid arthritis -- 4.4.2 Cardiometabolic diseases -- 4.5 Interkingdom interactions in the microbiome in diseases -- 4.6 Other omics data that hint at a difference in microbiome -- 4.7 Summary -- References -- Chapter 5 The evolving microbial taxonomy.

ISBN: 9780323913706Subjects--Topical Terms:

571470
Medical microbiology.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

Investigating human diseases with the microbiome = metagenomics bench to bedside /
LDR:04511nmm a2200289 a 4500 001 2415700
006 m o d
007 cr nn |||muauu
008 260207s2022 ne o 000 0 eng d
020 $a 9780323913706 $q (ebook)
020 $a 0323913709 $q (ebook)
020 $z 9780323913690 $q (paperback)
020 $z 0323913695 $q (paperback)
035 $a (OCoLC)1299444164
035 $a on1299444164
040 $a YDX $b eng $c YDX $d OPELS $d OCLCO $d UKMGB $d N$T $d OCLCF $d UKAHL $d SFB $d OCLCQ $d OCLCO $d OCLCL $d OCLCQ $d OCLCL
041 0 $a eng
050 4 $a QR46
082 0 4 $a 616.9041 $2 23
100 1 $a Jia, Huijue. $3 3793688
245 1 0 $a Investigating human diseases with the microbiome $h [electronic resource] : $b metagenomics bench to bedside / $c Huijue Jia.
260 $a Amsterdam : $b Academic Press, $c 2022.
300 $a 1 online resource (ix, 216 p.)
505 0 $a Intro -- Investigating Human Diseases with the Microbiome: Metagenomics Bench to Bedside -- Copyright -- Contents -- Acknowledgment -- Chapter 1 The supraorganism -- 1.1 New discoveries with new technology- A historical account -- 1.2 How many microbial cells can a human body have? -- 1.3 Viral particles in the human body -- 1.4 Microbiome in other species -- 1.5 Microbiome from ancient times -- 1.6 Summary -- References -- Chapter 2 Microbiota -- 2.1 Trophic levels in macroecology -- 2.2 Microbiome stability, diversity, and richness -- 2.3 De novo assembly of microbiota and robustness against invasions -- 2.4 Types of habitats for the skin microbiome -- 2.5 Forces shaping the oral microbiome -- 2.6 A stable gut microbiome -- 2.6.1 Adhesion -- 2.6.2 Peristalsis -- 2.7 "Enterotypes" and the Serengeti rules? -- 2.8 Summary -- References -- Chapter 3 Collecting samples for metagenomics -- 3.1 Nonmicrobial components in the sample that could influence DNA extraction and sequencing amount -- 3.2 Beware of contamination in each step, from stools to low-biomass samples -- 3.3 Reagents that prevent microbial growth after sampling -- 3.4 DNA extraction for metagenomic samples -- 3.5Sequencing amount -- 3.6 Taxonomic and functional profiles, absolute abundance -- 3.7 Sample size for metagenome-wide association studies -- 3.8 Summary -- References -- Chapter 4 Epidemiology in the human body -- 4.1 Analogy to COVID-19 --4.2 Sources of potential pathogens in the infant gut -- 4.3 Ectopic presence of commensal microbes -- 4.4 Get to where it matters for the disease -- 4.4.1 Rheumatoid arthritis -- 4.4.2 Cardiometabolic diseases -- 4.5 Interkingdom interactions in the microbiome in diseases -- 4.6 Other omics data that hint at a difference in microbiome -- 4.7 Summary -- References -- Chapter 5 The evolving microbial taxonomy.
505 8 $a 5.1 Approaching a closed reference set for routine applications -- 5.2 Sparser data with increasing taxonomic resolution -- 5.3 Evolutionary history below the species level -- 5.4 Whole-cell modeling to predict functional differences from genomic differences? -- 5.5 Summary -- References -- Chapter 6 Blurring the line between opportunistic pathogens and commensals -- 6.1 Causal reasoning 101 -- 6.2 Levels of existing evidence for the human microbiome and diseases -- 6.3 From microbes to molecules -- 6.3.1 Multiple effective molecules from Akkermansia muciniphila -- 6.3.2 Branched chain amino acids for muscles and diabetes -- 6.3.3 Molecular mimicry of autoantigens -- 6.3.4 Other examples, outer membranevesicles, phages -- 6.4 Summary -- References -- Chapter 7 Metagenomics from bench to bedside and from bedside to bench -- 7.1 Metagenomics for decision-making in diagnosis and treatment -- 7.1.1 Metagenomics for disease screening -- 7.1.2Metagenomics for personalized treatment -- 7.2 Further research to be inspired by clinical practice -- 7.3 Potential to modify existing categorization of diseases with knowledge of the microbiome -- 7.4 Summary -- References -- Chapter 8 Amicrobiome record for life -- 8.1 Proactive sampling of the microbiome at important time periods -- 8.1.1 A microbiome record from birth -- 8.1.2 Immediate and historical events for a wholesome microbiome -- 8.2 From genetic risk to the prevention of diseases -- 8.3 Summary -- References -- Index.
650 0 $a Medical microbiology. $3 571470
650 0 $a Microorganisms $x Health aspects. $3 3301470
655 4 $a Electronic books. $2 lcsh $3 542853
758 $i has work: $a INVESTIGATING HUMAN DISEASES WITH THE MICROBIOME (Text) $1 https://id.oclc.org/worldcat/entity/E39PD3JPXky7v9BvhpDmWg7XMP $4 https://id.oclc.org/worldcat/ontology/hasWork
776 0 8 $i Print version: $z 9780323913706
776 0 8 $i Print version: $z 0323913695 $z 9780323913690 $w (OCoLC)1264717392
856 4 0 $u https://www.sciencedirect.com/science/book/9780323913690